Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-004187-35Phase 3Active
Phase 3, randomised, double-blind trial in facial palsy, Bell's palsy and facial paresis comparing Prednisolone with Placebo (2 arms). Primary endpoint: Total recovery by House-Brackmann at 12 months. Started Oct 2018; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-004187-35.